Pulmonx Corporation

Get Full Access

Description

  • Pulmonx is focused on developing life-changing technologies that improve the lives of patients suffering from lung disease. The Companys first commercial products address emphysema, a form of COPD (chronic obstructive pulmonary disease) and the largest unmet medical need in Pulmonology. With emphysema, breathing becomes increasingly more difficult as the disease progresses. Today in the U.S., advanced emphysema patients have no available alternatives but lung volume reduction surgery, which is associated with high morbidity and mortality, and lung transplantation, which is limited by the availability of donor organs.Pulmonx has developed the Zephyr Endobronchial Valve (EBV) Therapy, a non-surgical, investigational approach to treating emphysema. The minimally invasive Zephyr valve is a tiny, one-way valve designed to reduce the volume of the diseased regions of the lung by blocking airflow, in order to improve breathing and increase activity levels. No surgery is involved in the simple, one-hour procedure. More than 25,000 Zephyr valves have been implanted outside the U.S. in the last 10 years. Clinical studies in Europe have shown that the majority of qualified patients who have the procedure see a significant improvement in lung function, exercise tolerance and quality of life.In the United States, Pulmonx is conducting the LIBERATE Clinical Study to evaluate the safety and effectiveness of the Zephyr valve in patients with severe emphysema.Pulmonx products are commercially available in Europe, Australia, Asia, Latin America and other countries worldwide. The company does not yet market or sell its products in the United States.CAUTION: The Zephyr Endobronchial Valve is an investigational device in the US, limited by US law to investigational use.
  • location

    Headquarters:700 Chesapeake Drive , Redwood City, California, United States

    More
  • Pulmonx Corporation phone

    Phone Number: +1 650-364-0400

  • Pulmonx Corporation website

    Website: https://www.pulmonx.com

  • Pulmonx Corporation employees

    Employees:186

  • Pulmonx Corporation revenue

    Revenue:$50 - 100M

  • Pulmonx Corporation legal name

    Legal Name:Pulmonx Corporation

  • Pulmonx Corporation's Social Media

    Pulmonx Corporation linkedin Pulmonx Corporation facebook Pulmonx Corporation twitter
  • done Is this data correct?
  • |  NAICS Code: 621111  |

    Show More
Person level website identification

CEO for Pulmonx Corporation

Glen French

Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Sri Radhakrishnan

Chief Technical Officer

Beran Rose

Chief Commercial Officer

Derrick Sung

Chief Financial Officer

Martin Schneider

Vice President Finance, Chief Financial Officer International

Mahtab Fatemi

Vice President Ra And Qa

Frequently Asked Questions regarding Pulmonx Corporation

  • Where are Pulmonx Corporation's Headquarters?

    Pulmonx Corporation's Headquarters are in 700 Chesapeake Drive ,Redwood City,California,United States

  • What is Pulmonx Corporation's phone number?

    Pulmonx Corporation's phone number is +1 650-364-0400

  • What is Pulmonx Corporation's official website?

    Pulmonx Corporation's official website is https://www.pulmonx.com

  • What is Pulmonx Corporation's Revenue?

    Pulmonx Corporation's revenue is $50 - 100M

  • What is Pulmonx Corporation's NAICS code?

    Pulmonx Corporation's NAICS code is 621111

  • How many employees are working in Pulmonx Corporation

    Pulmonx Corporation has 186 employees

  • What is Pulmonx Corporation's Industry?

    Pulmonx Corporation is in the industry of Medical Devices

  • Who is Pulmonx Corporation's CEO?

    Pulmonx Corporation's CEO is Glen French

Company Directory